Vera Therapeutics, Inc. (VERA) Insider Trading
Over the last 3 months, VERA insiders made 0 open-market buys and 7 sales, a net sale of -$2.4M (SEC Form 4). Over the last 6 months, 183 institutions increased and 128 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$2.4M
Insider trades by month Buys Sells
Nov
Dec
Feb
Apr
May
Jun
Context3-month price +6.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 88 | $38.43 |
| Jun 24, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 18,412 | $37.93 |
| May 26, 2026 | Cheng Andrewdirector | Grant | 17,084 | $34.35 |
| May 26, 2026 | Oliger Christy J.director | Grant | 17,084 | $34.35 |
| May 26, 2026 | Morrison Scott Wdirector | Grant | 17,084 | $34.35 |
| May 26, 2026 | SEIDENBERG BETH Cdirector | Grant | 17,084 | $34.35 |
| May 26, 2026 | Meyers James Rdirector | Grant | 17,084 | $34.35 |
| May 26, 2026 | Hall Kimballdirector | Grant | 17,084 | $34.35 |
| May 26, 2026 | MORRISSEY MICHAELdirector | Grant | 17,084 | $34.35 |
| May 26, 2026 | ENRIGHT PATRICK Gdirector | Grant | 17,084 | $34.35 |
| May 13, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 14,219 | $36.64 |
| May 13, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 4,281 | $37.09 |
| Apr 15, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 14,130 | $43.66 |
| Apr 15, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 900 | $45.51 |
| Apr 15, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 7,921 | $44.58 |
| Mar 25, 2026 | Wright-Mitchell Janeofficer: Chief Legal Officer | Grant | 56,850 | $40.73 |
| Mar 25, 2026 | Wright-Mitchell Janeofficer: Chief Legal Officer | Grant | 42,403 | — |
| Mar 16, 2026 | Young Joseph Rofficer: SVP, FINANCE, CHIEF ACCT OFFCR | Option | 10,000 | $3.94 |
| Mar 9, 2026 | Hite Christopherdirector | Grant | 24,937 | $38.85 |
| Feb 25, 2026 | Young Joseph Rofficer: SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3,117 | $41.98 |
| Feb 25, 2026 | Grant Seanofficer: CHIEF FINANCIAL OFFICER | Sell | 4,949 | $41.98 |
| Feb 25, 2026 | Fordyce Marshalldirector, officer: PRESIDENT AND CEO | Sell | 16,925 | $41.98 |
| Feb 25, 2026 | Skelton Laurence Matthewofficer: Chief Commercial Officer | Sell | 1,582 | $41.98 |
| Feb 25, 2026 | JOHNSON DAVID LEEofficer: Chief Operating Officer | Sell | 2,579 | $41.98 |
| Feb 25, 2026 | Turner William D.officer: Chief Regulatory Officer | Sell | 2,187 | $41.98 |
| Feb 25, 2026 | Brenner Robertofficer: Chief Medical Officer | Sell | 2,151 | $41.98 |
| Feb 6, 2026 | Turner William D.officer: Chief Regulatory Officer | Grant | 50,000 | $42.74 |
| Feb 6, 2026 | Skelton Laurence Matthewofficer: Chief Commercial Officer | Grant | 40,000 | $42.74 |
| Feb 6, 2026 | Skelton Laurence Matthewofficer: Chief Commercial Officer | Grant | 20,000 | — |
| Feb 6, 2026 | Young Joseph Rofficer: SVP, FINANCE, CHIEF ACCT OFFCR | Grant | 20,000 | $42.74 |
Source: VERA SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their VERA positions over the last 6 months (SEC Form 13F).
Increased
183
New positions
104
Reduced
128
Sold out
50
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | Reduced | 5.9M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 5.9M | Mar 16, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5.5M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5.4M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5.1M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 4.8M | Feb 12, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 4.6M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4.1M | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Increased | 4.1M | Feb 17, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Reduced | 3.7M | May 15, 2026 |
| VANGUARD GROUP INC | Increased | 3.6M | Jan 29, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Reduced | 3.4M | Feb 17, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Reduced | 3.4M | May 15, 2026 |
| STATE STREET CORP | Increased | 3.4M | May 15, 2026 |
| EVERSEPT PARTNERS, LP | Increased | 3.1M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.